SpaceX Shares Are Sliding: A Contrarian Buying Opportunity Worth Considering

SpaceX shares have pulled back from a June IPO peak of $225.64 to around $162 (still above the $135 IPO price), keeping the stock’s risk-reward debate active. Positives: Starlink contributed ~60% of $18.7B revenue in 2025 and $4.4B operating income, with 10.3M users and FCC approval to add 7,500 Gen2 satellites. Key catalysts include AI compute deals (Alphabet at $920M/month Oct 2026–Jun 2029; Anthropic at Colossus 1 capacity) and index inclusion in the Nasdaq-100 requiring estimated ~$4.3B of buying, but valuation remains rich (about 81x trailing sales) and execution risk persists around Starship delays.

Analysis

The near-term setup is dominated by positioning, not fundamentals: the float is tight, short interest is high, and the Nasdaq-100 event creates a forced-buyer window that can keep the stock dislocated for days to a few weeks. That said, this is exactly the kind of tape where the last marginal bid is mechanical, so the stock can continue higher even as the underlying business case gets less attractive on forward sales and cash-flow math.

The cleaner fundamental winner is NVDA, not SPCX. If the compute commitments are real and durable, the economics of AI infrastructure still accrue first to the chip supplier and networking stack; the operator of the capacity is carrying the capex, depreciation, and execution risk. By contrast, the market is likely overestimating how much of the headline contract value converts into near-term free cash flow for SPCX, especially if revenue ramps later than the market expects or if utilization takes time to fill.

Over 1-3 months, the main risk is that the post-index bid is exhausted and investors refocus on dilution, capex intensity, and Starship execution. Over 6-18 months, the key issue is whether satellite connectivity economics stay defensible as capacity expands; that matters for legacy satcom peers and rural telecom substitution, but it also raises the chance that the market starts treating Starlink as a mature infrastructure asset rather than a hypergrowth story. The contrarian read is that the move is likely front-loaded: the easy money is the inclusion squeeze, not the 12-18 month multiple expansion, unless management can prove accelerating monetization without a commensurate rise in capital intensity.

Key Decisions for Investors

• Tactically long SPCX into the Nasdaq-100 inclusion window only if it trades below the event-driven flow consensus; trim into strength after July 7, because the catalyst is mostly mechanical and likely to decay within 1-2 weeks.
• Pair trade: long NVDA / short SPCX over the next 1-3 months. If AI capacity demand is genuine, NVDA monetizes it with lower execution risk; if the demand proves overstated, SPCX absorbs the capex and contract risk. Use SPCX strength above the post-IPO range as the entry signal.
• Avoid chasing SPCX for a long-only position at current multiples unless management shows quarterly evidence of margin expansion and capex discipline; the thesis is falsified if operating leverage stalls or if Starship delays push out meaningful revenue realization by 2+ quarters.
• Watch NDAQ only as a flow beneficiary, not a thesis stock. Any upside from index-event turnover should be short-lived; fade it once rebalance volumes normalize.
• Set an alert on satellite/connectivity peers such as IRDM and GSAT: if Starlink capacity expansion starts showing up in pricing pressure or churn, that would create a cleaner 6-18 month short than chasing SPCX upside.